Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Motor Activity 9Neoplasms 6Pancreatic Neoplasms 3Lung Neoplasms 3Breast Neoplasms 3Esophageal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Rectal Neoplasms 1Peripheral Nervous System Diseases 1Neurocognitive Disorders 1Disease 1Colorectal Neoplasms 1Colonic Neoplasms 1Cognitive Dysfunction 1

Interventions

Oxaliplatin 10Leucovorin 9Fluorouracil 9Specimen Handling 6Cetuximab 6Bevacizumab 6Magnetic Resonance Spectroscopy 4pembrolizumab 3cemiplimab 3Pemetrexed 3fludarabine 2dehydroftorafur 2aldesleukin 2Surveys and Questionnaires 2Nivolumab 2Irinotecan 2Immunoglobulin G 2Gemcitabine 2Folfox protocol 2Disulfides 2Cyclophosphamide 2Cisplatin 2Carboplatin 2Biopsy 2ulixertinib 1trifluridine tipiracil drug combination 1trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1trametinib 1tipiracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colonic Neoplasms × Exercise × 30 days × Clear all
NCT07596732 2026-05-19

SUNRISE

AdventHealth Translational Research Institute

Phase NA Not yet recruiting
120 enrolled
GastrointestinalThoracic

Colonic Neoplasms, Disease, Esophageal Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡